Myeloid cell reprogramming alleviates immunosuppression and promotes clearance of metastatic lesions

HIGHLIGHTS

• who: Ravi M. Raghani from the University of Florida, United States have published the research work: Myeloid cell reprogramming alleviates immunosuppression and promotes clearance of metastatic lesions, in the Journal: (JOURNAL)
• what: In this study, cargo-free immunomodulatory PLG NPs were investigated in the 4T1 murine model of TNBC for therapeutic efficacy in the neoadjuvant and adjuvant setting to manage disease and treat metastasis. The authors report that cargo-free PLG NPs augment PT resection by abrogating distant recurrence when administered either as a neoadjuvant or adjuvant therapy.
• how: The authors investigated this . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.